New award offers young Stanford researchers $100,000 for improving health care access

Young Stanford researchers focusing on how to improve health care access in developing countries are eligible for a new $100,000 award.

The Dr. George Rosenkranz Prize will be given to a non-tenured professor, post-doctoral student or research associate during a two-year period.

Rosenkranz, who helped first synthesize Cortisone in 1951 and went on to synthesize progestin  – the active ingredient for the first oral birth control – dedicated his career to improving health care access around the world. Born in Hungary in 1916, the chemist started his career in Mexico and helped establish the Mexican National Institute for Genomic Medicine. He lives with his wife in Menlo Park.

The award is being funded by the Rosenkranz family and administered by Stanford Health Policy, a center within the Freeman Spogli Institute for International Studies and the Center for Primary Care and Outcomes Research. It also is designed to give its recipients access to a network that will help them develop their careers.

President Emeritus Donald Kennedy, Paul Yock, a professor of medicine and bioengineering, and Alan Garber, director of Stanford Health Policy, will serve on the initial selection committee and will mentor the award winners during their tenure at Stanford.

The application deadline is Feb. 1, and the first winner will be announced in March. More application information is available on Stanford Health Policy's website.